Your browser doesn't support javascript.
loading
Chromatin regulation by Histone H4 acetylation at Lysine 16 during cell death and differentiation in the myeloid compartment.
Urdinguio, Rocio G; Lopez, Virginia; Bayón, Gustavo F; Diaz de la Guardia, Rafael; Sierra, Marta I; García-Toraño, Estela; Perez, Raúl F; García, María G; Carella, Antonella; Pruneda, Patricia C; Prieto, Cristina; Dmitrijeva, Marija; Santamarina, Pablo; Belmonte, Thalía; Mangas, Cristina; Diaconu, Elena; Ferrero, Cecilia; Tejedor, Juan Ramón; Fernandez-Morera, Juan Luis; Bravo, Cristina; Bueno, Clara; Sanjuan-Pla, Alejandra; Rodriguez, Ramon M; Suarez-Alvarez, Beatriz; López-Larrea, Carlos; Bernal, Teresa; Colado, Enrique; Balbín, Milagros; García-Suarez, Olivia; Chiara, María Dolores; Sáenz-de-Santa-María, Inés; Rodríguez, Francisco; Pando-Sandoval, Ana; Rodrigo, Luis; Santos, Laura; Salas, Ana; Vallejo-Díaz, Jesús; C Carrera, Ana; Rico, Daniel; Hernández-López, Inmaculada; Vayá, Amparo; Ricart, José M; Seto, Edward; Sima-Teruel, Núria; Vaquero, Alejandro; Valledor, Luis; Cañal, Maria Jesus; Pisano, David; Graña-Castro, Osvaldo; Thomas, Tim.
Afiliação
  • Urdinguio RG; Nanomaterials and Nanotechnology Research Center (CINN-CSIC), Universidad de Oviedo-Principado de Asturias, Spain.
  • Lopez V; Cancer Epigenetics Laboratory, Institute of Oncology of Asturias (IUOPA), ISPA-Hospital Universitario Central de Asturias HUCA, Universidad de Oviedo, Oviedo, Spain.
  • Bayón GF; Nanomaterials and Nanotechnology Research Center (CINN-CSIC), Universidad de Oviedo-Principado de Asturias, Spain.
  • Diaz de la Guardia R; Cancer Epigenetics Laboratory, Institute of Oncology of Asturias (IUOPA), ISPA-Hospital Universitario Central de Asturias HUCA, Universidad de Oviedo, Oviedo, Spain.
  • Sierra MI; Josep Carreras Leukemia Research Institute and Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.
  • García-Toraño E; Centro de Investigación Biomédica en Red en Cáncer (CIBER-ONC), Barcelona, Spain.
  • Perez RF; Cancer Epigenetics Laboratory, Institute of Oncology of Asturias (IUOPA), ISPA-Hospital Universitario Central de Asturias HUCA, Universidad de Oviedo, Oviedo, Spain.
  • García MG; Cancer Epigenetics Laboratory, Institute of Oncology of Asturias (IUOPA), ISPA-Hospital Universitario Central de Asturias HUCA, Universidad de Oviedo, Oviedo, Spain.
  • Carella A; Nanomaterials and Nanotechnology Research Center (CINN-CSIC), Universidad de Oviedo-Principado de Asturias, Spain.
  • Pruneda PC; Cancer Epigenetics Laboratory, Institute of Oncology of Asturias (IUOPA), ISPA-Hospital Universitario Central de Asturias HUCA, Universidad de Oviedo, Oviedo, Spain.
  • Prieto C; Nanomaterials and Nanotechnology Research Center (CINN-CSIC), Universidad de Oviedo-Principado de Asturias, Spain.
  • Dmitrijeva M; Cancer Epigenetics Laboratory, Institute of Oncology of Asturias (IUOPA), ISPA-Hospital Universitario Central de Asturias HUCA, Universidad de Oviedo, Oviedo, Spain.
  • Santamarina P; Nanomaterials and Nanotechnology Research Center (CINN-CSIC), Universidad de Oviedo-Principado de Asturias, Spain.
  • Belmonte T; Cancer Epigenetics Laboratory, Institute of Oncology of Asturias (IUOPA), ISPA-Hospital Universitario Central de Asturias HUCA, Universidad de Oviedo, Oviedo, Spain.
  • Mangas C; Cancer Epigenetics Laboratory, Institute of Oncology of Asturias (IUOPA), ISPA-Hospital Universitario Central de Asturias HUCA, Universidad de Oviedo, Oviedo, Spain.
  • Diaconu E; Cancer Epigenetics Laboratory, Institute of Oncology of Asturias (IUOPA), ISPA-Hospital Universitario Central de Asturias HUCA, Universidad de Oviedo, Oviedo, Spain.
  • Ferrero C; Cancer Epigenetics Laboratory, Institute of Oncology of Asturias (IUOPA), ISPA-Hospital Universitario Central de Asturias HUCA, Universidad de Oviedo, Oviedo, Spain.
  • Tejedor JR; Nanomaterials and Nanotechnology Research Center (CINN-CSIC), Universidad de Oviedo-Principado de Asturias, Spain.
  • Fernandez-Morera JL; Cancer Epigenetics Laboratory, Institute of Oncology of Asturias (IUOPA), ISPA-Hospital Universitario Central de Asturias HUCA, Universidad de Oviedo, Oviedo, Spain.
  • Bravo C; Nanomaterials and Nanotechnology Research Center (CINN-CSIC), Universidad de Oviedo-Principado de Asturias, Spain.
  • Bueno C; Cancer Epigenetics Laboratory, Institute of Oncology of Asturias (IUOPA), ISPA-Hospital Universitario Central de Asturias HUCA, Universidad de Oviedo, Oviedo, Spain.
  • Sanjuan-Pla A; Cancer Epigenetics Laboratory, Institute of Oncology of Asturias (IUOPA), ISPA-Hospital Universitario Central de Asturias HUCA, Universidad de Oviedo, Oviedo, Spain.
  • Rodriguez RM; Cancer Epigenetics Laboratory, Institute of Oncology of Asturias (IUOPA), ISPA-Hospital Universitario Central de Asturias HUCA, Universidad de Oviedo, Oviedo, Spain.
  • Suarez-Alvarez B; Cancer Epigenetics Laboratory, Institute of Oncology of Asturias (IUOPA), ISPA-Hospital Universitario Central de Asturias HUCA, Universidad de Oviedo, Oviedo, Spain.
  • López-Larrea C; Cancer Epigenetics Laboratory, Institute of Oncology of Asturias (IUOPA), ISPA-Hospital Universitario Central de Asturias HUCA, Universidad de Oviedo, Oviedo, Spain.
  • Bernal T; Cancer Epigenetics Laboratory, Institute of Oncology of Asturias (IUOPA), ISPA-Hospital Universitario Central de Asturias HUCA, Universidad de Oviedo, Oviedo, Spain.
  • Colado E; Cancer Epigenetics Laboratory, Institute of Oncology of Asturias (IUOPA), ISPA-Hospital Universitario Central de Asturias HUCA, Universidad de Oviedo, Oviedo, Spain.
  • Balbín M; Josep Carreras Leukemia Research Institute and Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.
  • García-Suarez O; Centro de Investigación Biomédica en Red en Cáncer (CIBER-ONC), Barcelona, Spain.
  • Chiara MD; Hematology Research Group, Instituto de Investigación Sanitaria La Fe (IIS La Fe), Valencia, 46026, Spain.
  • Sáenz-de-Santa-María I; Translational Immunology Laboratory, Instituto de Investigación Sanitarias del Principado de Asturias (ISPA), Immunology Department, Hospital Universitario Central de Asturias (HUCA), Oviedo, Spain.
  • Rodríguez F; Translational Immunology Laboratory, Instituto de Investigación Sanitarias del Principado de Asturias (ISPA), Immunology Department, Hospital Universitario Central de Asturias (HUCA), Oviedo, Spain.
  • Pando-Sandoval A; Translational Immunology Laboratory, Instituto de Investigación Sanitarias del Principado de Asturias (ISPA), Immunology Department, Hospital Universitario Central de Asturias (HUCA), Oviedo, Spain.
  • Rodrigo L; Servicio de Hematología, Hospital Universitario Central de Asturias (HUCA), Oviedo, Spain.
  • Santos L; Servicio de Hematología, Hospital Universitario Central de Asturias (HUCA), Oviedo, Spain.
  • Salas A; Service of Molecular Oncology, Hospital Universitario Central de Asturias, Instituto Universitario de Oncología del Principado de Asturias, Universidad de Oviedo, Oviedo, Spain.
  • Vallejo-Díaz J; Department of Morphology and Cellular Biology, Faculty of Medicine, University of Oviedo, Oviedo, Spain.
  • C Carrera A; Otorhinolaryngology Service, Hospital Universitario Central de Asturias, Instituto Universitario de Oncología del Principado de Asturias, Universidad de Oviedo, CIBERONC, Oviedo, Spain.
  • Rico D; Otorhinolaryngology Service, Hospital Universitario Central de Asturias, Instituto Universitario de Oncología del Principado de Asturias, Universidad de Oviedo, CIBERONC, Oviedo, Spain.
  • Hernández-López I; Departamento de Bioquímica y Biología Molecular, Facultad de Medicina, Instituto Universitario de Oncología (IUOPA), Universidad de Oviedo, Oviedo, Spain.
  • Vayá A; Hospital Universitario Central de Asturias (HUCA), Instituto Nacional de Silicosis (INS), Área del Pulmón, Facultad de Medicina, Universidad de Oviedo, Avenida Roma s/n, Oviedo, Asturias 33011, Spain.
  • Ricart JM; Hospital Universitario Central de Asturias (HUCA), Gastroenterology Service, Facultad de Medicina, Universidad de Oviedo, Avenida de Roma s/n, Oviedo, Asturias 33011, Spain.
  • Seto E; Fundación para la Investigación Biosanitaria de Asturias (FINBA). Instituto de Investigación Sanitaria del Principado de Asturias (ISPA). Avenida de Roma s/n, 33011 Oviedo. Asturias. España.
  • Sima-Teruel N; Cytometry Service, Servicios Científico-Técnicos (SCTs). Universidad de Oviedo, Oviedo, Spain.
  • Vaquero A; Department of Immunology and Oncology, National Center for Biotechnology, CNB-CSIC, Cantoblanco, 28049 Madrid, Spain.
  • Valledor L; Department of Immunology and Oncology, National Center for Biotechnology, CNB-CSIC, Cantoblanco, 28049 Madrid, Spain.
  • Cañal MJ; Institute of Cellular Medicine, Newcastle University, UK.
  • Pisano D; Institute of Cellular Medicine, Newcastle University, UK.
  • Graña-Castro O; Hemorheology and Haemostasis Unit, Service of Clinical Pathology, La Fe University Hospital, Valencia, Spain.
  • Thomas T; Dermatology Service, Quirón Clinic, Valencia, Spain.
Nucleic Acids Res ; 47(10): 5016-5037, 2019 06 04.
Article em En | MEDLINE | ID: mdl-30923829
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cromatina / Histonas / Diferenciação Celular / Apoptose / Células Mieloides / Lisina Limite: Animals / Humans Idioma: En Revista: Nucleic Acids Res Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cromatina / Histonas / Diferenciação Celular / Apoptose / Células Mieloides / Lisina Limite: Animals / Humans Idioma: En Revista: Nucleic Acids Res Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Espanha